ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

Adenocarcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Randomized Controlled ◽

ESOPEC: A prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy to neoadjuvant chemoradiation in patients with adenocarcinoma of the esophagus (NCT02509286).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps4131 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS4131-TPS4131

Author(s):

Jens Hoeppner ◽

Florian Lordick ◽

Thomas B. Brunner ◽

Torben Glatz ◽

Claudia Schmoor ◽

...

Keyword(s):

Neoadjuvant Chemoradiation ◽

Phase Iii ◽

Adenocarcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma

Journal of Chemotherapy ◽

10.1179/joc.2003.15.2.184 ◽

2003 ◽

Vol 15 (2) ◽

pp. 184-191 ◽

Cited By ~ 12

Author(s):

A.M. Capotorto ◽

L. Pavesi ◽

P. Pedrazzoli ◽

G.A. Da Prada ◽

C. Zamagni ◽

...

Keyword(s):

Breast Carcinoma ◽

Mitomycin C ◽

Standard Dose ◽

Metastatic Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Metastatic Breast Carcinoma ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10541957.11392056 ◽

2011 ◽

Author(s):

Tanios Bekaii-Saab ◽

Katherine Martin

Keyword(s):

Phase Iii ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Gastroesophageal Adenocarcinoma

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

Annals of Surgical Oncology ◽

10.1245/s10434-015-4968-3 ◽

2015 ◽

Vol 23 (4) ◽

pp. 1309-1319 ◽

Cited By ~ 61

Author(s):

Marybeth S. Hughes ◽

Jonathan Zager ◽

Mark Faries ◽

H. Richard Alexander ◽

Richard E. Royal ◽

...

Keyword(s):

Liver Metastases ◽

Phase Iii ◽

Phase Iii Trial ◽

Hepatic Perfusion ◽

Randomized Controlled ◽

Multicenter Phase ◽

Percutaneous Hepatic Perfusion

Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial

Journal of Neuro-Oncology ◽

10.1007/s11060-010-0427-y ◽

2010 ◽

Vol 103 (3) ◽

pp. 595-602 ◽

Cited By ~ 21

Author(s):

Il Han Kim ◽

Chul-Kee Park ◽

Dae Seog Heo ◽

Chae-Yong Kim ◽

Chang Hun Rhee ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Multicenter Phase ◽

Adjuvant Temozolomide

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Yearbook of Oncology ◽

10.1016/j.yonc.2011.08.020 ◽

2011 ◽

Vol 2011 ◽

pp. 186-187

Author(s):

J.T. Thigpen

Keyword(s):

Phase Iii ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Gastroesophageal Adenocarcinoma

1646: An Adjuvant Autologous Renal Tumor cell Vaccine (ATL) Reduces the Risk of Progression in Patients with Renal Cell Carcinoma Following Radical Nephrectomy: Final Results of a Multicenter Phase-III Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)38854-2 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 435-435

Author(s):

Christian Doehn ◽

Axel Richter ◽

Walter Lehmacher ◽

Dieter Jocham

Keyword(s):

Renal Cell Carcinoma ◽

Tumor Cell ◽

Renal Cell ◽

Renal Tumor ◽

Phase Iii ◽

Cell Vaccine ◽

Tumor Cell Vaccine ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Risk Of Progression

Custodiol-N versus custodiol: A prospective randomized double blind multicenter phase III trial

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-0034-1367380 ◽

2014 ◽

Vol 62 (S 01) ◽

Author(s):

G. Szabó ◽

A. Weymann ◽

B. Schmack ◽

D. Badowsky-Zyla ◽

G. Veres ◽

...

Keyword(s):

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3358963.3047062 ◽

2010 ◽

Author(s):

Elfyn Thomas

Keyword(s):

Subarachnoid Hemorrhage ◽

Magnesium Sulphate ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Phase Iii ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Intravenous Magnesium ◽

Double Blinded

Laparoscopic Sentinel Node Navigation Surgery Versus Laparoscopic Standard Gastrectomy with Lymph Node Dissection for Early Gastric Cancer: Postoperative Morbidity and Mortality Results of Prospective Multicenter Phase III Trial (SENORITA)

SSRN Electronic Journal ◽

10.2139/ssrn.3426078 ◽

2019 ◽

Author(s):

Ji Yeong An ◽

Jae Seok Min ◽

Hoon Hur ◽

Young Joon Lee ◽

Gyu Seok Cho ◽

...

Keyword(s):

Gastric Cancer ◽

Lymph Node ◽

Early Gastric Cancer ◽

Postoperative Morbidity ◽

Phase Iii ◽

Node Dissection ◽

Navigation Surgery ◽

Sentinel Node Navigation Surgery ◽

Phase Iii Trial ◽